These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 8371702)

  • 21. New hope for an AIDS vaccine.
    Robinson HL
    Nat Rev Immunol; 2002 Apr; 2(4):239-50. PubMed ID: 12001995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 1999: a time to re-evaluate AIDS vaccine strategies.
    Ruprecht RM; Hofmann-Lehmann R; Rasmussen RA; Vlasak J; Xu W
    J Hum Virol; 2000; 3(2):88-93. PubMed ID: 10850895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. So far so good for HIV vaccine.
    CMAJ; 1997 Jun; 156(12):1692. PubMed ID: 9220914
    [No Abstract]   [Full Text] [Related]  

  • 24. What are the correlates of protection?
    Cohen J
    Science; 1993 May; 260(5112):1259. PubMed ID: 8493565
    [No Abstract]   [Full Text] [Related]  

  • 25. Trick and treat: toward peptide mimic vaccines.
    Shikhman AR; Cunningham MW
    Nat Biotechnol; 1997 Jun; 15(6):512-3. PubMed ID: 9181569
    [No Abstract]   [Full Text] [Related]  

  • 26. [AIDS vaccine].
    Sikorska EJ
    Pneumonol Alergol Pol; 1991; 59(3-4):146-52. PubMed ID: 1843911
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunology. New virtual center aims to speed AIDS vaccine progress.
    Cohen J
    Science; 2005 Jul; 309(5734):541. PubMed ID: 16040673
    [No Abstract]   [Full Text] [Related]  

  • 28. AIDS 1998. Vaccines and immunology: overview.
    Stott J; Hu SL
    AIDS; 1998; 12 Suppl A():S95-6. PubMed ID: 9632990
    [No Abstract]   [Full Text] [Related]  

  • 29. AIDS vaccine predictions.
    Barin F
    Nature; 1987 Jul 2-8; 328(6125):21. PubMed ID: 3474526
    [No Abstract]   [Full Text] [Related]  

  • 30. Candidate AIDS vaccines.
    Graham BS; Wright PF
    N Engl J Med; 1995 Nov; 333(20):1331-9. PubMed ID: 7566026
    [No Abstract]   [Full Text] [Related]  

  • 31. Induction of HIV-specific memory T-cell responses by topical DermaVir vaccine.
    Calarota SA; Weiner DB; Lori F; Lisziewicz J
    Vaccine; 2007 Apr; 25(16):3070-4. PubMed ID: 17292518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of vaccination strategies that elicit broadly neutralizing antibodies against human immunodeficiency virus type 1 in both the mucosal and systemic immune compartments.
    Hone DM; DeVico AL; Fouts TR; Onyabe DY; Agwale SM; Wambebe CO; Blattner WA; Gallo RC; Lewis GK
    J Hum Virol; 2002; 5(1):17-23. PubMed ID: 12352264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Induction of neutralizing antibodies against HIV-1 viruses in HLA-DQ6 mice by peptide vaccines].
    Takahashi A
    Hokkaido Igaku Zasshi; 1998 Mar; 73(2):147-56. PubMed ID: 9612708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quest for an effective AIDS vaccine takes a new tack.
    Maurice J
    Lancet; 2011 Jul; 378(9787):213-4. PubMed ID: 21770060
    [No Abstract]   [Full Text] [Related]  

  • 35. HIV-1/AIDS vaccine development: are we in the darkness.
    Qiu C; Xu JQ
    Chin Med J (Engl); 2008 May; 121(10):939-45. PubMed ID: 18706210
    [No Abstract]   [Full Text] [Related]  

  • 36. India targets local HIV strain in test of AIDS vaccine.
    Jayaraman KS
    Nature; 2004 Jan; 427(6971):185. PubMed ID: 14724601
    [No Abstract]   [Full Text] [Related]  

  • 37. How should the potency of HIV vaccine candidates be determined?
    Sheets R; Bean P
    Am Clin Lab; 2000; 19(8):23. PubMed ID: 11146989
    [No Abstract]   [Full Text] [Related]  

  • 38. Is AIDS vaccine research at a turning point?
    Levy JP
    J Hum Virol; 2000; 3(2):83-7. PubMed ID: 10850894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV-1 neutralizing antibodies: how full is the bottle?
    Moore JP; Burton DR
    Nat Med; 1999 Feb; 5(2):142-4. PubMed ID: 9930854
    [No Abstract]   [Full Text] [Related]  

  • 40. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
    Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW
    J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.